Development of a Predictive Model of Occult Cancer After a Venous Thromboembolism Event Using Machine Learning: The CLOVER Study.

Journal: Medicina (Kaunas, Lithuania)
PMID:

Abstract

: Venous thromboembolism (VTE) can be the first manifestation of an underlying cancer. This study aimed to develop a predictive model to assess the risk of occult cancer between 30 days and 24 months after a venous thrombotic event using machine learning (ML). : We designed a case-control study nested in a cohort of patients with VTE included in a prospective registry from two Spanish hospitals between 2005 and 2021. Both clinically and ML-driven feature selection were performed to identify predictors for occult cancer. XGBoost, LightGBM, and CatBoost algorithms were used to train different prediction models, which were subsequently validated in a hold-out dataset. : A total of 815 patients with VTE were included (51.5% male and median age of 59). During follow-up, 56 patients (6.9%) were diagnosed with cancer. One hundred and twenty-one variables were explored for the predictive analysis. CatBoost obtained better performance metrics among the ML models analyzed. The final CatBoost model included, among the top 15 variables to predict hidden malignancy, age, gender, systolic blood pressure, heart rate, weight, chronic lung disease, D-dimer, alanine aminotransferase, hemoglobin, serum creatinine, cholesterol, platelets, triglycerides, leukocyte count and previous VTE. The model had an ROC-AUC of 0.86 (95% CI, 0.83-0.87) in the test set. Sensitivity, specificity, and negative and positive predictive values were 62%, 94%, 93% and 75%, respectively. : This is the first risk score developed for identifying patients with VTE who are at increased risk of occult cancer using ML tools, obtaining a remarkably high diagnostic accuracy. This study's limitations include potential information bias from electronic health records and a small cancer sample size. In addition, variability in detection protocols and evolving clinical practices may affect model accuracy. Our score needs external validation.

Authors

  • Anabel Franco-Moreno
    Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.
  • Elena Madroñal-Cerezo
    Department of Internal Medicine, Hospital Universitario de Fuenlabrada, 28942 Madrid, Spain.
  • Cristina Lucía de Ancos-Aracil
    Department of Internal Medicine, Hospital Universitario de Fuenlabrada, 28942 Madrid, Spain.
  • Ana Isabel Farfán-Sedano
    Department of Internal Medicine, Clínica Universidad de Navarra-Hospital, 31008 Pamplona, Spain.
  • Nuria Muñoz-Rivas
    Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.
  • José Bascuñana Morejón-Girón
    Department of Internal Medicine, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • José Manuel Ruiz-Giardín
    Department of Internal Medicine, Hospital Universitario de Fuenlabrada, 28942 Madrid, Spain.
  • Federico Álvarez-Rodríguez
    Department of Anatomical Pathology, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.
  • Jesús Prada-Alonso
    Horus-ML, Alcalá Street 268, 28027 Madrid, Spain.
  • Yvonne Gala-García
    Horus-ML, Alcalá Street 268, 28027 Madrid, Spain.
  • Miguel Ángel Casado-Suela
    Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.
  • Ana Bustamante-Fermosel
    Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.
  • Nuria Alfaro-Fernández
    Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.
  • Juan Torres-Macho
    Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.